Diapositive 1

1638-1639 / 1674

University Hospital Erlangen
Clinical outcome
 2nd local recurrence: 4.1%
 Regional recurrence: 0.5%
 Distant metastasis: 10.1%
Median follow-up (years):
- from the primary 14.5 [3.5 – 38.2]
- from the recurrence 3.9 [1.1 – 10.3]